Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph early_phase_1
5
100%

Phase Distribution

5

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
5(100.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Other(5)

Detailed Status

unknown5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
N/A
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 15 (100.0%)

Trials by Status

unknown5100%

Recent Activity

0 active trials
Showing 5 of 5
unknownearly_phase_1

68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Stroke

NCT01656785
unknownearly_phase_1

68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma

NCT01801371
unknownearly_phase_1

68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid Arthritis

NCT01940926
unknownearly_phase_1

68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer Patients

NCT01527058
unknownearly_phase_1

68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Myocardial Infarction

NCT01542073

Clinical Trials (5)

Showing 5 of 5 trials
NCT01656785Early Phase 1

68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Stroke

Unknown
NCT01801371Early Phase 1

68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma

Unknown
NCT01940926Early Phase 1

68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid Arthritis

Unknown
NCT01527058Early Phase 1

68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer Patients

Unknown
NCT01542073Early Phase 1

68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Myocardial Infarction

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5